Sintilimab,Cisplatin,Paclitaxel,5-fluorouracil
Innovent Biologics,eli lilly
['sintilimab', 'orient-15', 'orien', 'esophageal', 'innovent']
innovent releases final analysis results of orient-15: the phase 3 study of sintilimab plus chemotherapy for the first-line treatment of esophageal squamous cell carcinoma at the aacr annual meeting 2023 #prnewswire #prnewswire
Stock Market News and Press Releases. #StockMarket & #Crypto